Skip to main content

TableĀ 3 Semi-quantitative and quantitative parameters in csPCa and non-csPCa group

From: Values of multiparametric and biparametric MRI in diagnosing clinically significant prostate cancer: a multivariate analysis

Parameter

Non-csPCa

csPCa

U

P

PSAD (ng/mL2)

0.124 (0.069, 0.250)

0.280 (0.076, 739)

15,350.000

ā€‰<ā€‰0.001

Age (years)

67 (62, 72)

68 (62, 74)

36,161.500

0.099

PI-RADS (points)

2 (1, 3)

5 (4, 5)

8256.500

ā€‰<ā€‰0.001

T2WI (points)

2 (2, 3)

5 (4, 5)

9204.500

ā€‰<ā€‰0.001

ADC (Ɨā€‰10āˆ’3mm2/s)

1.024 (0.851, 1.200)

0.680 (0.577, 0.779)

12,627.000

ā€‰<ā€‰0.001

Kep (/min)

1.390 (1.014, 1.980)

1.893 (1.125,2.619)

30,359.500

ā€‰<ā€‰0.001

Ktrans (/min)

1.018(0.660, 1.414)

1.264(0.674, 1.830)

32,728.500

ā€‰<ā€‰0.001

  1. csPCa clinically significant prostate cancer, PSAD Prostate specific antigen density, PI-RADS Prostate imaging reporting and data system, T2WI T2 weighted image, ADC Apparent diffusion coefficient, Ktrans volume transfer constant between blood plasma and the extracellular extravascular space, Kep rate constant between the extracellular extravascular space and the blood plasma. Data are expressed as M (Q1, Q3)